We recommend that % Print
patients use this tool in ! Settings
consultation with their
doctor.
This tool is only for use
in men without
metastatic disease
where conservative
management and
radical treatment are
both options being
considered.
Reset
Age at
" diagnosis – 59 +
" PSA (ng/ml) – 5.2 +
" Clinical T stage 1 2 3 4
Hospital
" admission in No Yes
last 2 years?
" BRCA Negative or Untested Positive
" Ethnic Origin Please click on the info button
Histological
" grade group 1 2 3 4 5
" Gleason score 3+3 3+4 4+3 8 9 or 10
Biopsy data
" available? No Yes
Biopsy cores
" taken – 8 +
Biopsy cores taken from a MRI directed
target site are considered as 1 core
regardless of the number of biopsy
cores taken. See examples and FAQs.
Biopsy cores
with any
" prostate – 3 +
cancer in
Biopsy cores taken from a MRI directed
target site are considered as 1 core
regardless of the number of biopsy
cores taken. See examples and FAQs.
Is there an
intra-ductal
carcinoma or
invasive
" cribriform No Yes Unknown
component
reported in the
biopsies?
# This tool does not account for intra-
ductal carcinoma or invasive cribriform
component. If you're unsure use the
data with caution and please consult
your medical professional.
Has the cancer
" spread No Yes Unknown
(metastasis)?
Results
Charts Icons Curves Table
Texts
Treatment
" Regime Conservative Radical
This graph shows the percentage of men
surviving at 10 and 15 years. These results are
based on the inputs and treatments you
selected
Overall Survival
100% 100%
88% survive
90%
at least 10 90%
80% years 73% survive
80%
at least 15
70% years 70%
60% 60%
50% 50%
40% 40%
30% 30%
20% 20%
10% 10%
0% 0%
10 15
years after diagnosis
Survival excluding deaths from prostate
cancer
Initial conservative management
Important
These results are estimates based on data
from men with similar characteristics.
There are other important factors which
affect outcomes. Your specialist will help
you put these results in context.
$ Scroll down for potential harms
Potentially permanent harms of
Conservative management
Radical prostatectomy
Radical Radiotherapy
The following estimates are not individualised to you
or your local treatment centre. Your local team may
have data specific to your centre which you can ask
about.
If you are in the UK, centre by centre provider
outcomes are provided by the National Prostate
Cancer Audit which you may find useful:
https://www.npca.org.uk/provider-results/.
Erectile dysfunction
Defined as: 'Erections not firm enough for
intercourse'
Percentages shown include men who may already have this
problem before any treatment is given
With conservative management (men who did not
subsequently change to radical treatment), about 66 in 100
men have this issue after 3 6 9 12 years.
66%
With radical prostatectomy (surgery), about 84 in 100 men
have this issue after 3 6 9 12 years.
84%
With radical radiotherapy (external beam), about 73 in 100
men have this issue after 3 6 9 12 years.
73%
Estimates for erectile dysfunction have been taken from
the UK-based Prostate Testing for Cancer and Treatment
(ProtecT) trial. The full research can be read here:
https://evidence.nejm.org/doi/10.1056/EVIDoa2300018
Incontinence
Defined as: 'Use of 1 or more pads per day in the
past 4 weeks and assuming this problem does not
exist before treatment'
With conservative management (men who did not
subsequently change to radical treatment), about 2 in 100
men have this issue after 3 6 9 12 years.
2%
With radical prostatectomy (surgery), about 17 in 100 men
have this issue after 3 6 9 12 years.
17%
With radical radiotherapy (external beam), about 4 in 100
men have this issue after 3 6 9 12 years.
4%
Estimates for incontinence have been taken from the UK-
based Prostate Testing for Cancer and Treatment
(ProtecT) trial. The full research can be read here:
https://evidence.nejm.org/doi/10.1056/EVIDoa2300018
Bowel issues
Defined as: 'Bloody stools about half the time or
more frequently'
With conservative management, about 1 in 100 men have this
issue after 3 6 9 12 years.
1%
With radical prostatectomy (surgery), about 1 in 100 men
have this issue after 3 6 9 12 years.
1%
With radical radiotherapy (external beam), about 6 in 100
men have this issue after 3 6 9 12 years.
6%
Estimates for bowel issues have been taken from the UK-
based Prostate Testing for Cancer and Treatment
(ProtecT) trial. The full research can be read here:
https://evidence.nejm.org/doi/10.1056/EVIDoa2300018
More Information
The following websites provide excellent advice
and information on treatments and their
potential harms:
About treatments:
Cancer research UK
NHS
About potential harms:
Radical prostatectomy
Radiotherapy
Further advice and support:
Macmillan
Prostate Cancer UK
NHS Choices
Looking for advice?
See the FAQs
Copyright Ⓒ 2024 University of Cambridge. All Rights Reserved |
Privacy & Data Protection | Disclaimer
v-1.1-1.15
